Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,415 public trials 1,033 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

NCT00093821

Conditions: Childhood Chronic Myelogenous Leukemia, Childhood Desmoplastic Small Round Cell Tumor, Desmoplastic Small Round Cell Tumor, +36 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

NCT00006373

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

NCT00006363

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Erythroid Leukemia (M6), +47 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

NCT00049192

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +14 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia

NCT00017472

Conditions: Chronic Disease, Disease Attributes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +34 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

NCT00659568

Conditions: Adenocarcinoma, Blood Protein Disorders, Breast Cancer, +84 more
Locations: London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

NCT00045006

Conditions: Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +110 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00138164

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

BCX-1777 in Treating Patients With Refractory Cancer

NCT00073944

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +140 more
Locations: Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

NCT00849654

Conditions: B-cell Leukemia, B-cell Lymphoma, Blood Protein Disorders, +31 more
Locations: Stanford University School of Medicine Palo Alto, California, United States

University of Chicago Chicago, Illinois, United States

National Cancer Institute Bethesda, Maryland, United States

New York Prebyterian Hospital Cornell Medical Center New York, United States

View Trial Details

Leukemia

Leukemia trial results

Related conditions